Progesterone receptors: saturation analysis by a solid phase hydroxylapatite adsorption technique.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 7448725)

Published in Cancer on December 15, 1980

Authors

P G Hoffman, L A Jones, R W Kuhn, P K Siiteri

Articles by these authors

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (1989) 31.55

High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry (1999) 5.54

Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med (1978) 4.28

Communication within the emergency department: how do you get the word out? J Emerg Nurs (1994) 3.29

Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry (1999) 3.07

Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab (1973) 2.91

In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B. J Exp Med (1990) 2.69

Placental characteristics and reduced risk of maternal breast cancer. J Natl Cancer Inst (2001) 2.67

Adipose tissue as a source of hormones. Am J Clin Nutr (1987) 2.57

Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man. J Clin Invest (1970) 2.23

Amino acid sequence of monkey amyloid protein A. Biochemistry (1972) 2.17

Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol (1978) 2.07

Polydactyly and psychosis. Five cases of co-occurrence. Br J Psychiatry (1998) 2.02

Hospital delays and problems with thrombolytic administration in patients receiving thrombolytic therapy: a multicenter prospective assessment. Virginia Thrombolytic Study Group. Ann Emerg Med (1992) 1.97

Placental estrogen biosynthesis during human pregnancy. J Clin Endocrinol Metab (1966) 1.92

The serum transport of steroid hormones. Recent Prog Horm Res (1982) 1.91

History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev (2009) 1.88

Active sodium and potassium transport in high potassium and low potassium sheep red cells. J Gen Physiol (1971) 1.87

Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab (1985) 1.77

Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J Biol Chem (1974) 1.71

Guidelines for bacteriophage characterization. Adv Virus Res (1978) 1.66

Expanded CAG repeats in schizophrenia and bipolar disorder. Nat Genet (1995) 1.66

Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med (1994) 1.63

Ophthalmic microsurgical robot and associated virtual environment. Comput Biol Med (1995) 1.62

Thymic requirement for clonal deletion during T cell development. Science (1989) 1.60

Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab (1974) 1.59

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. Clin Cancer Res (2001) 1.59

Aggressive behaviour in patients with schizophrenia is associated with catechol-O-methyltransferase genotype. Br J Psychiatry (2001) 1.56

The involvement of human placental microsomal cytochrome P-450 in aromatization. J Biol Chem (1974) 1.51

Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab (1974) 1.51

Perception of force and weight: theory and research. Psychol Bull (1986) 1.51

Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med (1996) 1.49

Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog. J Clin Invest (1970) 1.48

The species concept and its application to tailed phages. Arch Virol (1992) 1.45

p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol (1999) 1.45

Delayed androgen treatment prolongs survival in murine lupus. J Clin Invest (1979) 1.43

Relative weight, weight change, height, and breast cancer risk in Asian-American women. J Natl Cancer Inst (1996) 1.39

Myocardial contrast echocardiography for the assessment of coronary blood flow reserve: validation in humans. J Am Coll Cardiol (1993) 1.39

Regulation of the transmembrane potential of isolated chromaffin granules by ATP, ATP analogs, and external pH. J Biol Chem (1976) 1.39

A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. Hum Mol Genet (1999) 1.37

Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet (1983) 1.37

Purification and properties of a carboxypeptidase inhibitor from potatoes. J Biol Chem (1974) 1.34

Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum (1979) 1.33

Isolation and partial characterization of an acid carboxypeptidase from yeast. Biochemistry (1974) 1.30

Myopia and ambient night-time lighting. CLEERE Study Group. Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error. Nature (2000) 1.29

Steroid hormones and endometrial cancer. Cancer Res (1978) 1.28

AC/A ratio, age, and refractive error in children. Invest Ophthalmol Vis Sci (2000) 1.28

No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am J Psychiatry (1996) 1.28

Corneal reshaping and myopia progression. Br J Ophthalmol (2009) 1.25

A systematic genomewide linkage study in 353 sib pairs with schizophrenia. Am J Hum Genet (2003) 1.24

Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats. J Nucl Med (1998) 1.22

Origin of estrogen in normal men and in women with testicular feminization. J Clin Endocrinol Metab (1979) 1.22

CD54 is a surrogate marker of antigen presenting cell activation. Cancer Immunol Immunother (2008) 1.22

Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity. J Virol (2001) 1.21

Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant? Ann N Y Acad Sci (1977) 1.20

Serum sex hormone-binding globulin capacity and the percentage of free estradiol in postmenopausal women with and without endometrial carcinoma. A new biochemical basis for the association between obesity and endometrial carcinoma. Am J Obstet Gynecol (1980) 1.19

Plasma precursors of estrogen. I. Extent of conversion of plasma delta-4-androstenedione to estrone in normal males and nonpregnant normal, castrate and adrenalectomized females. J Clin Endocrinol Metab (1967) 1.19

Mechanism of immunosuppression of progesterone on maternal lymphocyte activation during pregnancy. J Immunol (1979) 1.18

Effect of fatigue on force sensation. Exp Neurol (1983) 1.18

Massive extranglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy. J Clin Invest (1977) 1.16

Progesterone binding components of chick oviduct. X. Purification by affinity chromatography. J Biol Chem (1975) 1.15

Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk. Int J Cancer (1987) 1.14

Steroids as immunosuppressants in pregnancy. Immunol Rev (1983) 1.14

Hormonal correlates of 'masculinization' in female spotted hyaenas (Crocuta crocuta). 2. Maternal and fetal steroids. J Reprod Fertil (1992) 1.14

Estrogen receptors and the estrone hypothesis in relation to endometrial and breast cancer. Gynecol Oncol (1974) 1.14

Ocular predictors of the onset of juvenile myopia. Invest Ophthalmol Vis Sci (1999) 1.13

Human adrenodoxin reductase: two mRNAs encoded by a single gene on chromosome 17cen----q25 are expressed in steroidogenic tissues. Proc Natl Acad Sci U S A (1988) 1.13

Sporicidal activity of peracetic acid and beta-propiolactone at subzero temperatures. Appl Microbiol (1967) 1.13

Repeated delivery of adeno-associated virus vectors to the rabbit airway. J Virol (1999) 1.12

Assessment of the role of the glucocorticoid system in aging processes and in the action of food restriction. J Gerontol (1991) 1.11

Partial duplication of the long arm of chromosome 5: a case due to balanced paternal translocation and review of the literature. Hum Genet (1979) 1.11

Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. J Biol Chem (1980) 1.11

Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol (1996) 1.11

CD8 is required during positive selection of CD4-/CD8+ T cells. J Exp Med (1990) 1.11

Preparation and certain properties of highly purified streptokinase. J Biol Chem (1967) 1.09

Interstitial deletion of the long arm of chromosome 2: case report and review of literature. Ann Genet (1981) 1.09

Immunologic and endocrine interrelationships in pregnancy. Biol Reprod (1982) 1.08

Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone. Cancer Epidemiol Biomarkers Prev (1996) 1.07

Cigarette smoking in a multiethnic population of youth: methods and baseline findings. Prev Med (1998) 1.06

When do auditory/visual differences in duration judgements occur? Q J Exp Psychol (Hove) (2006) 1.05

Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. J Natl Cancer Inst (1987) 1.02

Chromosomal radiosensitivity in G2-phase lymphocytes as an indicator of cancer predisposition. Radiat Res (1996) 1.01

Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial. Cancer Res (2000) 1.00

WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Am J Pathol (1997) 1.00

The life-cycle of an actionophage for Streptomyces venezuelae. J Gen Microbiol (1965) 1.00

A mechanism for virilization of female spotted hyenas in utero. Science (1993) 1.00

Control of cell proliferation: evidence for negative control on estrogen-sensitive T47D human breast cancer cells. Cancer Res (1986) 0.98

Serum concentrations of total and non-protein-bound oestradiol in patients with breast cancer and in normal controls. Int J Cancer (1982) 0.98

The neuropsychiatric phenotype in Darier disease. Br J Dermatol (2010) 0.98

Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats. Nucl Med Biol (1999) 0.98

Tamoxifen therapy of epithelial ovarian cancer. Obstet Gynecol (1985) 0.97

Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine. Environ Health Perspect (1997) 0.97

Quantitation of fecal carbohydrate excretion in patients with short bowel syndrome. Gastroenterology (1987) 0.96

Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival. Cancer Res (1995) 0.96

Force sensation in isometric contractions: a relative force effect. Brain Res (1982) 0.96

Aromatization and 5alpha-reduction of androgens in discrete hypothalamic and limbic regions of the male and female rat. Endocrinology (1977) 0.96

Free estradiol in postmenopausal women with and without endometrial cancer. J Clin Endocrinol Metab (1981) 0.96

Factor analysis of schizophrenic symptoms using the OPCRIT checklist. Schizophr Res (1996) 0.96